Eledon Pharmaceuticals, Inc. (ELDN) Shareholders’ equity

Eledon Pharmaceuticals, Inc. (ELDN) shareholders’ equity at each fiscal year-end, per SEC filings.

-$2.7MFY2016

Fiscal year	Value	YoY
FY2016	-$2.7M	—

Source: SEC XBRL filings · For reference only · Not investment advice

More ELDN financial trends

ELDN Revenue ELDN Net income ELDN Net margin ELDN Gross profit ELDN Gross margin ELDN Operating income ELDN Operating margin ELDN Operating cash flow ELDN Free cash flow ELDN Capital expenditures ELDN Return on equity ELDN Stock buybacks ELDN Dividends paid ELDN Total assets ELDN Total liabilities ELDN overview →